RecruitingNCT06844643
The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study
Sponsor
China-Japan Friendship Hospital
Enrollment
2,250 participants
Start Date
Mar 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Patients aged 18 years or older
- Diagnosis of axial spondyloarthritis (axSpA) according to the Assessment of Spondyloarthritis International Society (ASAS) classification criteria
Exclusion Criteria4
- Presence of severe, unstable medical conditions that may interfere with the study assessments, including but not limited to:
- End-stage renal disease (eGFR < 30 mL/min/1.73m²) Severe cardiovascular disease Active malignancy or malignancy requiring ongoing treatment
- Current diagnosis of schizophrenia, other psychotic disorders, severe cognitive impairment, or epilepsy with recurrent uncontrolled seizures, which, in the opinion of the investigator, may impair the ability to provide informed consent or comply with follow-up visits.
- Pregnant or lactating women
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06844643
Related Trials
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
NCT0688819312 locations
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
NCT0729003642 locations
Oxidative Stress in Autoimmune Rheumatic Diseases
NCT075365291 location
Evaluating the Efficacy and Short-Term Prognosis of Integrated Traditional Chinese and Western Medicine for Ankylosing Spondylitis(AS): A Protocol for a Cohort Study
NCT075562241 location
A Study of SPY072 in Rheumatic Disease
NCT0714841457 locations